Director, HTA, Value & Evidence (HV&E) – Supportive Care

Pfizer, S.A. de C.V; Paris; Hybride; USD 169 000 - 283 000; Plein temps

Résumé du poste

An established industry player is seeking a Director for HTA, Value & Evidence in Supportive Care. This pivotal role will drive optimal patient access for supportive care medicines, focusing on strategic guidance and robust evidence generation. The ideal candidate will manage health economics and outcomes research while collaborating with cross-functional teams to foster innovation. With a competitive salary and comprehensive benefits, this opportunity is perfect for a passionate professional eager to make a difference in patient care.

Prestations

Employee referral bonus

401(k) plan with matching contributions

Paid vacation and personal days

Health benefits including dental and vision

Qualifications

• 7+ years of experience in HEOR or related fields.
• Excellent oral and written communication skills in English.

Responsabilités

• Provide strategic input into clinical trial designs.
• Lead the development of global HEOR studies.

Connaissances

Health Economics

Project Management

Interpersonal Skills

Statistical Analysis

Communication Skills

Formation

Graduate degree (MSc, MPH, PhD)

Outils

Health Economic Modeling Tools

Description du poste

Director, HTA, Value & Evidence (HV&E) – Supportive Care

• United States - Washington – Bothell
• United States - New York - New York City
• United States - Pennsylvania - Collegeville
• United States - Massachusetts - Cambridge

We’re in relentless pursuit of breakthroughs that change patients’ lives. We innovate every day to make the world a healthier place.

To fully realize Pfizer’s purpose – Breakthroughs that change patients’ lives – we have established a clear set of expectations regarding “what” we need to achieve for patients and “how” we will go about achieving those goals.

Pfizer offers competitive compensation and benefits programs designed to meet the diverse needs of our colleagues.

The Director, HV&E – Supportive Care will support the strategic goals of the Oncology Division by driving optimal patient access for supportive care medicines.

This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal patient access by demonstrating the value of our supportive care medicines. The HV&E Director will be responsible for developing and executing against the global evidence generation strategy, including direct oversight of evidence generation activities and dissemination of technical deliverables.

The Director will be part of Pfizer’s dynamic Global Access & Value (GAV) team and will have the important role of managing health economics and outcomes research (HEOR) to generate data to support patient access to supportive care medicines, with a focus on ponsegromab. This position will be working closely with the GAV, cross-functional and country teams to foster a culture that promotes innovation and thrives on doing better for Pfizer’s patients and healthcare.

ROLE RESPONSIBILITIES

• Provide strategic input into clinical trial designs (eg, patient populations, comparators, endpoints) and analysis to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers.
• Develop and execute the clinical outcomes assessment strategy and incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence aligned with overall asset strategy and to ensure global reimbursement and access requirements.
• Lead the development and execution of the Value & Evidence Strategy (VES) to support the value of supportive care assets in the Oncology Division in close partnership with the cross-functional matrix team and local country/regional teams.
• Lead the design and execution of global HEOR studies (eg, network meta-analyses, non-interventional studies, economic models) from concept through publication.
• Lead the timely development of launch deliverables including global value dossiers/AMCP dossiers, systematic literature reviews, economic models, and innovative tools to successfully support reimbursement and access requirements in conjunction with the regions/countries.
• Partner with internal stakeholders to ensure appropriate customer facing dissemination of HEOR materials per regulatory guidance and internal SOPs.
• Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, payers, and various academic and community oncology settings to support asset strategies.

BASIC QUALIFICATIONS

• Graduate degree required (e.g. MSc, MPH, PhD)
• 7+ years of experience required with MSc/MPH/MBA degree; 5+ years of experience required with PharmD/PhD in HEOR or relevant related fields (health economics, epidemiology, health services research, or other research-focused public health field)
• Demonstrated in depth understanding of fundamental health services research methods and tools, including health economic modeling, patient-reported outcomes, statistics, and real-world evidence studies including technical and methodological aspects of registries and observational study design, implementation, analysis and interpretation. Capable of independently managing complex non-interventional study projects
• Knowledge and understanding of drug development process
• Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers
• Excellent oral and written English communication skills
• Demonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordingly
• An “execution mindset” focused on getting things done quickly and simply
• Strong project management abilities (contracting, budgeting, vendor management) essential. Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities
• Ability to influence key members of medical, clinical, and commercial teams constructively and without conflict
• Skilled in functioning within a matrix organization and managing through influence
• Organized and detail oriented with the ability to anticipate needs and to work proactively to prioritize and address/resolve issues
• Change oriented and comfortable responding to unexpected demands with tight timelines; team player

PREFERRED QUALIFICATIONS

• Knowledge and experience in the oncology therapeutic area is highly preferred along with experience with supportive care products
• Experience with creative cost-effective modeling approaches (eg, leveraging aspects of the ISPOR Value Flower)
• Experience interacting with country teams and knowledge of global HTA requirements and HTA organizations (eg, NICE, GBA, HAS, CDA, PBAC, ICER)

Other Job Details:

• Last Date to Apply for Job:May 16th, 2025
• Position is hybrid and will require to work from site 2 to 3 days per week
• NOT Eligible for Relocation Package
• Eligible for employee referral bonus
• Ability to travel domestically and internationally
• Ability to work in all US time zones

The annual base salary for this position ranges from $169,700.00 to $282,900.00.* In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 20.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.* The annual base salary for this position in Tampa, FL ranges from $152,700.00 to $254,500.00.

Relocation assistance may be available based on business needs and/or eligibility.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. This position requires permanent work authorization in the United States.